1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
17 
(2) Members of the Commission who are full-time 
officers or employees of the United States shall receive no 
additional pay on account of their service on the Commission. 
Sec. 202. The Commission shall conduct — 
(a) (1) a study of the current state of knowledge of 
the dangers of recombinant DNA research including an 
evaluation of whether the Federal guidelines concerning 
such research are needed and, if needed, whether they 
are adequate ; 
(2) a study of the likely directions of recombinant 
DNA research in the future and the potential risks 
associated with such research ; and 
(3) a study of the appropriate role of the public in 
determining governmental policy concerning recom- 
binant DNA research including a study of the appro- 
priate roles of Federal, State, and local governments in 
assessing the risks associated with such research; 
i 
(b) a study of the long-term consequences of the 
development of a technology capable of accomplishing 
the genetic modification of organisms and viruses in- 
cluding in such study — 
(1) an evaluation of the anticipated applica- 
tions of genetic manipulation technology to such 
areas as medicine, pharmacology, immunology, in- 
dustrial fermentation, and agriculture; and 
[Appendix B — 41] 
